UK-headquartered pharmaceutical giant AstraZeneca, under scanner over potential side effects associated with its COVID-19 vaccine, has reiterated its commitment to patient safety after acknowledging that the vaccine can, in "very rare cases", cause a blood clot related side effect amongst those administered its vaccine., India News - Times Now